VERAgene - a comprehensive NIPT test that screens for 100 monogenic diseases

During pregnancy, cell-free fetal DNA travels from the placenta and circulates in the mother’s blood along with her own cell-free DNA. This discovery led to the development of Non-Invasive Prenatal Tests (NIPT). NIPT is a test taken by a pregnant woman that screens for certain genetic conditions in the fetus before birth. The benefit of NIPT is that it is performed much earlier during pregnancy and is more accurate than traditional screening tests currently in practice. While there are many NIPTs for Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13), sex chromosome (X & Y) aneuploidies (chromosomal changes) and microdeletions (loss of a small section of a chromosome), an NIPT test that stands out is VERAgene.

Designed and developed by NIPD Genetics, VERAgene is the only comprehensive NIPT test that can simultaneously screen for common aneuploidies, selected clinically significant microdeletions and a panel of 100 single gene (monogenic) diseases, like β-thalassemia, cystic fibrosis and phenylketonurea. Aneuploidies such as Down syndrome are screened by many NIPT and traditional screening tests due to their severity and incidence rate. However, the 4 microdeletions and the single gene diseases that are additionally detected by VERAgene cannot be detected prenatally by any other means apart from NIPT, as biochemical or ultrasound indications for many of these disorders are often non-existent. Additionally, they are not associated with maternal age so they can manifest at any age group – even ones that are not traditionally referred for prenatal screening. Consequently, if these genetic conditions are not detected before birth, it could take a lot of time for examination and specific testing for a person to be diagnosed; time that could have otherwise been spent receiving the appropriate treatment.

The 100 monogenic diseases screened by VERAgene are often severe with significant impact on the quality of life. These genetic diseases exhibit symptoms such as congenital anomalies, developmental delays, hearing loss, blindness and failure to thrive. VERAgene screens for autosomal recessive and X-linked diseases. In autosomal recessive conditions, both parents have to be carriers of the same disease variant (genetic change) for their baby to be affected. In X-linked conditions, where the variant is on the X chromosome, the variant is often passed from carrier, unaffected mothers to their male offsprings. As males only have one X chromosome, they are always affected. Importantly, people who are carriers do not exhibit any disease symptoms. Unless they have had pre-conception testing, have a family history of a specific condition, or live in regions where certain diseases have high prevalence – such as β-thalassemia in the Mediterranean or Tay-Sachs in Israel – they won’t necessarily know their status, or their risk of having an affected pregnancy. The cumulative incidence rate of all 100 monogenic diseases, aneuploidies and microdeletions detected by VERAgene is approximately 1 in 50 in moderate to high-risk pregnancies. Thus, VERAgene provides a high value to doctors and expecting parents by providing them with a comprehensive picture of the pregnancy with a single test that helps them make informed decisions early on during the pregnancy.

VERAgene is based on the same proprietary technology as NIPD Genetics’s new generation NIPT, VERACITY, which tests for aneuploidies in 21, 18, 13, X and Y chromosomes and select microdeletions. VERAgene can be performed as early as the 10th week of gestation and it only requires a blood sample from the biological mother and a buccal swab sample from the biological father. These samples are sent from the clinician to the NIPD Genetics laboratory for analysis. The maternal blood contains cell-free DNA from both the mother and the fetus. Cell-free fetal DNA is isolated from the maternal blood and is analyzed along with the father’s DNA sample for any potential variants. The results are sent back to the clinician within 7 working days, who then communicates them to the parents and provides the necessary counselling. Like other screening tests, a positive result indicates that there is higher chance of the embryo being affected – it doesn’t provide a diagnosis – and it should be confirmed with an invasive procedure, such as amniocentesis. The sample taken from this procedure is analyzed using the same advanced technology of NIPD Genetics without any additional charge, as part of the complete testing offered. VERAgene can be performed in singleton and twin pregnancies, and is also applicable for self-IVF pregnancies.

The advantage VERAgene offers – to screen for monogenic diseases which do not have any age-associated risk in addition to aneuploidies and microdeletions – is of significant importance for patients and healthcare practitioners alike. VERAgene combines the unparalleled accuracy and superiority of NIPD Genetics’s technology in a testing panel that provides a cost-effective, comprehensive analysis that opens a new chapter in the field of non-invasive prenatal screening.

VERAgene was launched by NIPD Genetics in 2018 and screened for aneuploidies, microdeletions and 50 single gene diseases of autosomal recessive inheritance. In January 2020, VERAgene was expanded to screen for aneuploidies, microdeletions and 100 single gene diseases of autosomal recessive and X-linked inheritance.

To learn more about all the conditions screened by VERAgene, please visit NIPT results, possible next steps and clinical management should always be fully discussed with your healthcare provider.

View All Posts

NIPD Genetics - Privacy Policy

General Statement

This Privacy Policy applies only to and its subdomains (hereafter collectively referred to as “Sites") that link to this policy. NIPD Genetics Sites are owned by NIPD Genetics Public Company Ltd and are operated by NIPD Genetics Public Company Ltd and on occasion by a third-party that is responsible for the technical maintenance of the Sites.

If, you do not agree with this Privacy Policy, please do not access or use any of NIPD Genetics Sites.

NIPD Genetics values your interest in NIPD Genetics, its products and its services. NIPD Genetics takes the protection of your data seriously.

Personal data for purposes of this Privacy Policy, is any information by which you can be individually identified, including, but not limited to, your name, profession, address, e-mail address, and telephone number.

You may contact NIPD Genetics Public Company Ltd at
NIPD Genetics Public Company Ltd
Neas Engomis 31
Engomi, Nicosia
2409, Cyprus

NIPD Genetics Data Protection Officer can be reached at

This Privacy Policy applies only to the Sites as defined above and which are operated by NIPD Genetics. The NIPD Genetics Privacy Policy seeks to inform the users of its Sites of the following:

NIPD Genetics will not use or share your information with anyone, except as described in this Privacy Policy. This Privacy Policy does not apply to any information we might collect by other digital and offline means and or from other digital and offline sources. The use of information collected through our Sites shall be limited to the purposes under this Privacy Policy and our Terms of Use to customers.

This page informs you of our policies regarding the collection, use, and disclosure of personal data when you use our Sites and the choices you have associated with that data.

We use your data to provide and improve the Sites. By using the Sites, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy Policy, terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, accessible from

Type of personal information NIPD Genetics may collect through its Sites

Information Collection And Use

We collect several different types of information for various purposes to provide and improve our Sites and services to you.

Personal Data

While using NIPD Genetics Sites, you may be asked to provide NIPD Genetics certain personally identifiable information that can be used to contact or identify you ("Personal Information"). Personal Information that might be used to identify you includes, but is not limited to:

If you send us a query via our Contact us form, your email address, the content and any follow up emails are retained indefinitely.

Cookies and Usage Data

Usage Data

We may also collect information how the Sites are accessed and used ("Usage Data"). This Usage Data may include information such as your computer's Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Sites that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.

Tracking & Cookies Data

We use cookies and similar tracking technologies to track the activity on our Sites and hold certain information.

Cookies are files with small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Tracking technologies also used are beacons, tags, and scripts to collect and track information and to improve and analyze our Sites.

You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Sites.

Examples of Cookies we use:

Session Cookies. We use Session Cookies to operate our Sites.

Preference Cookies. We use Preference Cookies to remember your preferences and various settings.

Security Cookies. We use Security Cookies for security purposes.

Visitor behavior cookies. To understand how visitors use and navigate the Sites

Keyword cookies. To understand how visitors discover the Sites.

Use of Data uses the collected data for various purposes:

Transfer of Data

Your information, including personal data, may be transferred to — and maintained on — computers located outside of your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.

If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.

Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer. will take all reasonable steps necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your personal data will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.

Disclosure of Data

NIPD Genetics complies with the protection of personal data regulation and will not sale or trade your personal data.

NIPD Genetics may disclose your personal data in the good faith belief that such action is necessary to:

Security of Data

The security of your data is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.

Service Providers

We may employ third party companies and individuals to facilitate, maintain or operate our Sites ("Service Providers"), to provide the SItes on our behalf, to perform service-related services or to assist us in analyzing how our Sites is used.

These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.


We may use third-party Service Providers to monitor and analyze the use of our Sites.

Google Analytics

Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.

You can opt-out of having made your activity on the Service available to Google Analytics by installing the Google Analytics opt-out browser add-on. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) from sharing information with Google Analytics about visits activity.

For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page

Access to your personal data, correction, deletion, and Opting Out

You have the right to review, update or delete any of your personal data by sending a request at NIPD Genetics Personal Data Officer

Links to Other Sites

Our Sites may contain links to other sites that are not operated by us. If you click on a third-party link, you will be directed to that third party's site. We strongly advise you to review the Privacy Policy of every site you visit.

We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.

Children's Privacy

Our Service does not address anyone under the age of 18 ("Children").

We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Children has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.

Changes to This Privacy Policy

We may update our Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.

We will let you know via email and/or a prominent notice on our Service, prior to the change becoming effective and update the "effective date" at the top of this Privacy Policy.

You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.

Contact Us

If you have any questions about this Privacy Policy, please contact

Ok got it!